ArticleHealth science reports2026
Genotype-Phenotype Discordance in Cardiomyopathies: Pathophysiology, Clinical Expression, and Therapeutic Considerations.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiomyopathies encompass a spectrum of myocardial disorders often attributed to underlying genetic mutations. However, genotype-phenotype discordance where the genetic profile does not align with the expected clinical presentation poses significant diagnostic, prognostic, and therapeutic challenges. Objective: To review the mechanisms underlying genotype-phenotype discordance in cardiomyopathies, explore its clinical implications, and propose future research directions to bridge the gap between molecular findings and patient outcomes. Methods: A narrative review was conducted using PubMed, Scopus, and Embase for articles published between 2000 and 2025. Search terms included "genotype-phenotype discordance", "cardiomyopathy", "penetrance", "expressivity", "modifier genes", and "epigenetics". Included studies focused on genetic and clinical variability in hypertrophic, dilated, arrhythmogenic, and restrictive cardiomyopathies. Priority was given to cohort studies, family-based analyses, and mechanistic investigations addressing epigenetic, polygenic, and environmental contributors to phenotypic heterogeneity. Results: Multiple factors contribute to genotype-phenotype discordance in cardiomyopathies, including incomplete penetrance, variable expressivity, epigenetic regulation, modifier genes, and environmental influences such as exercise and comorbidities. This discordance complicates risk stratification and personalized therapy. Clinically, individuals with pathogenic variants may remain asymptomatic, while others without identified mutations may exhibit overt disease. Emerging tools such as polygenic risk scores, multi-omics integration, and longitudinal phenotyping are improving phenotype prediction. Conclusion: Genotype-phenotype discordance in cardiomyopathies underscores the complexity of translating genetic insights into clinical practice. A multidimensional approach combining genetic, molecular, and environmental data is essential to refine diagnosis, guide management, and inform genetic counseling. Future research should focus on deep phenotyping, systems biology, and longitudinal cohort studies to unravel the dynamic interplay between genes and environment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.